MTMichael W. Tao

Michael W. Tao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Michael W. Tao has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    An Analysis of Biologic Therapies in Patients With Asthma and Chronic Rhinosinusitis

    by Mitchell R. Gore, Ethan Fung, Michael Tao

    Asthma, Allergic rhinitis (AR), Chronic Obstructive Pulmonary Disease (COPD), Eczema, and Chronic Rhinosinusitis with Sinonasal Polyposis (CRSwNP) are illnesses often characterized by type 2 (T2) inflammation, wherein T helper (Th) cells release pro-inflammatory cytokines such as IL (interleukin)-4, IL-5, IL-9, and IL-13. This response may also promote the production of IgE and an increase in/activation of serum eosinophils. In the aforementioned type 2 inflammatory diseases, this immune response can cause excess mucous production, inflammation of the airways, other atopic responses when patients are exposed to certain environmental allergic triggers. Relatively new biologic monoclonal antibody therapies such as dupilumab (blocks IL-4 and IL-13), benralizumab (blocks IL-5), mepolizumab (blocks IL-5), and omalizumab (blocks IgE Fc/fragment of crystallization region) offer novel therapeutic targets that more specifically and directly block type 2 inflammatory responses. To examine the effect of monoclonal antibody biologic therapies on patient indicators of type 2 inflammation, a retrospective analysis of 193 patients on biologic therapy was conducted, and these patients were compared to 48 control patients with type 2 inflammatory diseases who did not initiate biologic therapy. Total Lund-MacKay radiographic score, FEV1 (forced expiratory volume in the first second), FEF25-75 (forced expiratory flow from 25-75% of the forced vital capacity curve), annualized pulmonary exacerbations, oral corticosteroid dose, and serum eosinophils were recorded at baseline (zero months), and at three, six, nine, and twelve months after initiation of biologic therapy. Least squares mean data and the percent change from the baseline of least squares mean for the biologic and control groups were compared. Omalizumab was the most common biologic therapy prescribed. Control patients were younger than patients who initiated biologic therapy. Patients on biologic therapy had statistically significant reductions in Lund-MacKay score, improvements in FEV1 and FEF25-75, reductions in serum IgE levels, and reductions in serum Eosinophils. Patients on biologic therapy also had statistically significant reductions in annualized pulmonary exacerbations and oral corticosteroid dose compared to controls. Patients with a variety of type 2 inflammatory conditions appear to have significant improvements in lung function, radiographic sinusitis, and serum markers of type 2 inflammation after initiation of biologic therapy versus controls. These therapeutic medications appear to significantly improve type 2 inflammatory disease course in patients who can tolerate these medications.


  • Open Access

    Shape Estimation from Shading, Defocus, and Correspondence Using Light-Field Angular Coherence

    by Michael W. Tao, Pratul P. Srinivasan, Sunil Hadap, Szymon Rusinkiewicz, Jitendra Malik, Ravi Ramamoorthi

    Light-field cameras are quickly becoming commodity items, with consumer and industrial applications. They capture many nearby views simultaneously using a single image with a micro-lens array, thereby providing a wealth of cues for depth recovery: defocus, correspondence, and shading. In particular, apart from conventional image shading, one can refocus images after acquisition, and shift one's viewpoint within the sub-apertures of the main lens, effectively obtaining multiple views. We present a principled algorithm for dense depth estimation that combines defocus and correspondence metrics. We then extend our analysis to the additional cue of shading, using it to refine fine details in the shape. By exploiting an all-in-focus image, in which pixels are expected to exhibit angular coherence, we define an optimization framework that integrates photo consistency, depth consistency, and shading consistency. We show that combining all three sources of information: defocus, correspondence, and shading, outperforms state-of-the-art light-field depth estimation algorithms in multiple scenarios.


  • Open Access

    Error-Tolerant Image Compositing

    by Michael W. Tao, Micah K. Johnson, Sylvain Paris